Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
| Image |  |
|---|---|
| Description | scientific article published on 22 April 2020 |
| Author/s |
author: Kenji Tamura Kyaw L Aung Armando Santoro Jan H M Schellens Michael J Pishvaian Janice Mehnert |
| Publication date | April 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |